U.S. FDA Grants Orphan Drug Designation for KaloBios' KB001-A in Treatment of Cystic Fibrosis Patients

October 30, 2013

Source: Humanigen, Inc.

Released October 30, 2013

  • Twitter

©2020 Humanigen, Inc.  All rights reserved